Update: 17.10.2022
Last week: 40 week 2022 (03.10.2022 - 09.10.2022)
Last full month: September 2022
| Time period | Volume, packs | Change, % | MS Volume | Change, p.p. | Value, rur | Change, % | MS Value | Change, p.p. | Cat. Volume Change, % |
|---|---|---|---|---|---|---|---|---|---|
| BROMHEXINE BERLIN-CHEMIE | |||||||||
| WoW | 170 146 | -10.7% | 3.9% | 0.3 | 35 361 434 | -11.1% | 4.0% | 0.2 | -16.5% |
| MoM | 747 528 | 79.1% | 3.7% | 0 | 153 590 034 | 85.1% | 3.8% | 0.1 | 81.0% |
| YTD | 7 899 692 | -9.8% | 5.4% | -0.8 | 1 569 229 870 | 6.2% | 5.2% | -0.4 | 3.3% |
| MAT | 12 411 626 | 10.2% | 5.8% | 0.3 | 2 382 768 986 | 27.7% | 5.5% | 0.6 | 3.8% |
| DEXALGIN | |||||||||
| WoW | 21 836 | -4.0% | 0.4% | 0.1 | 10 642 519 | -2.8% | 1.4% | 0.2 | -18.5% |
| MoM | 90 811 | 16.9% | 0.4% | 0 | 43 312 453 | 19.6% | 1.1% | 0 | 21.7% |
| YTD | 1 369 214 | 7.1% | 0.7% | 0 | 579 688 287 | 19.3% | 1.9% | 0.1 | 3.1% |
| MAT | 1 930 079 | 9.6% | 0.7% | 0.1 | 794 739 114 | 19.8% | 2.0% | 0.1 | 1.7% |
| ESPUMISAN (ADULTS) | |||||||||
| WoW | 57 131 | -11.5% | 42.9% | -1 | 29 996 333 | -12.3% | 49.0% | -0.3 | -9.5% |
| MoM | 281 557 | 10.8% | 46.3% | -0.4 | 148 737 462 | 10.9% | 52.0% | -0.6 | 11.7% |
| YTD | 3 631 087 | -7.6% | 55.9% | -10.5 | 1 845 934 440 | 3.4% | 61.3% | -9.1 | 9.8% |
| MAT | 4 981 705 | -2.0% | 58.0% | -8 | 2 486 110 054 | 9.9% | 63.4% | -6.7 | 11.6% |
| ESPUMISAN BABY | |||||||||
| WoW | 24 519 | -10.4% | 33.6% | -1.3 | 16 078 303 | -10.6% | 47.0% | -1.1 | -7.0% |
| MoM | 112 687 | 10.3% | 34.9% | -0.1 | 73 791 527 | 12.4% | 48.2% | 0.5 | 10.7% |
| YTD | 1 150 630 | -10.3% | 38.2% | -3.6 | 717 704 468 | -3.8% | 51.4% | -5.2 | -1.9% |
| MAT | 1 531 636 | -10.8% | 38.6% | -3.1 | 943 058 701 | -3.4% | 52.1% | -3.8 | -3.8% |
| FASTUM | |||||||||
| WoW | 14 858 | -18.5% | 0.8% | -0.1 | 8 416 527 | -16.4% | 2.1% | -0.1 | -10.8% |
| MoM | 77 456 | 19.6% | 0.9% | 0 | 42 173 280 | 18.5% | 2.2% | 0.1 | 15.2% |
| YTD | 855 011 | -20.6% | 1.1% | -0.3 | 440 923 580 | -11.0% | 2.5% | -0.6 | 1.9% |
| MAT | 1 162 438 | -19.3% | 1.2% | -0.3 | 585 852 949 | -10.4% | 2.6% | -0.6 | 1.3% |
| IODOMARIN | |||||||||
| WoW | 89 074 | -26.8% | 25.2% | -2.8 | 16 395 732 | -26.6% | 11.2% | -3 | -18.6% |
| MoM | 335 689 | 32.6% | 24.3% | 2.3 | 62 171 772 | 28.4% | 10.7% | 1 | 20.3% |
| YTD | 2 459 499 | 7.9% | 19.9% | 0.2 | 485 977 071 | 13.4% | 9.0% | 0 | 6.9% |
| MAT | 3 346 819 | 25.0% | 20.7% | 2.8 | 649 763 421 | 26.6% | 9.4% | 1.1 | 8.1% |
| LIOTON | |||||||||
| WoW | 16 053 | -14.6% | 1.7% | -0.1 | 17 323 613 | -15.7% | 3.7% | 0 | -10.5% |
| MoM | 83 625 | -9.1% | 1.8% | -0.2 | 90 280 193 | -8.4% | 3.9% | -0.4 | 1.3% |
| YTD | 1 063 173 | -21.9% | 2.3% | -0.5 | 1 089 097 870 | -2.0% | 4.7% | -0.9 | -6.1% |
| MAT | 1 394 663 | -18.6% | 2.4% | -0.4 | 1 380 473 357 | 0.1% | 4.9% | -0.7 | -6.0% |
| MEZYM | |||||||||
| WoW | 217 591 | -12.0% | 18.9% | 0.4 | 34 072 187 | -9.4% | 13.9% | 0.8 | -13.7% |
| MoM | 1 012 478 | 8.5% | 18.9% | -0.8 | 154 387 022 | 9.1% | 13.4% | -0.5 | 13.2% |
| YTD | 14 704 550 | -0.7% | 27.2% | -0.6 | 2 250 096 850 | 8.6% | 19.5% | -1.3 | 1.5% |
| MAT | 20 660 863 | 6.8% | 28.6% | 0.9 | 3 086 347 528 | 14.1% | 20.6% | -0.2 | 3.5% |
| MIG 400 | |||||||||
| WoW | 140 488 | -18.5% | 2.8% | 0 | 16 923 139 | -18.2% | 2.2% | 0 | -18.5% |
| MoM | 705 306 | 16.2% | 2.8% | -0.1 | 83 916 288 | 16.1% | 2.2% | 0 | 21.7% |
| YTD | 6 777 858 | -10.0% | 3.4% | -0.5 | 797 470 411 | -6.0% | 2.5% | -0.5 | 3.1% |
| MAT | 9 134 627 | -4.2% | 3.4% | -0.2 | 1 065 787 990 | -0.1% | 2.6% | -0.3 | 1.7% |
| PROSTAMOL | |||||||||
| WoW | 28 814 | 11.1% | 17.7% | 3 | 39 937 140 | 10.2% | 18.7% | 3 | -8.0% |
| MoM | 107 142 | 27.2% | 15.1% | 0 | 149 162 441 | 25.9% | 16.1% | 0.2 | 27.1% |
| YTD | 1 270 573 | -22.2% | 19.4% | -5.7 | 1 782 007 163 | -12.9% | 20.7% | -6.7 | 0.7% |
| MAT | 1 777 865 | -17.0% | 20.3% | -4.4 | 2 435 517 020 | -8.8% | 21.7% | -5.3 | 0.8% |
| RESPERO MYRTOL | |||||||||
| WoW | 28 451 | -0.2% | 9.3% | 1.7 | 13 954 205 | 1.7% | 9.7% | 1.7 | -18.3% |
| MoM | 111 511 | 68.8% | 7.7% | -1.4 | 53 402 083 | 71.8% | 8.0% | -1.2 | 99.0% |
| YTD | 967 524 | 137.3% | 8.9% | 4.9 | 453 191 791 | 135.3% | 8.7% | 4.4 | 5.0% |
| MAT | 1 306 573 | 127.2% | 8.6% | 4.5 | 605 468 516 | 121.2% | 8.4% | 3.9 | 7.7% |
| Brand | Volume, packs | Change, % | MS Volume | Change, p.p. | Value, rur | Change, % | MS Value | Change, p.p. | Cat. Volume Change, % |
|---|---|---|---|---|---|---|---|---|---|
| BROMHEXINE B-CH | 7 899 692 | -9.8% | 5.4% | -0.8 | 1 569 229 870 | 6.2% | 5.2% | -0.4 | 3.3% |
| DEXALGIN | 1 369 214 | 7.1% | 0.7% | 0 | 579 688 287 | 19.3% | 1.9% | 0.1 | 3.1% |
| ESPUMISAN (ADULTS) | 3 631 087 | -7.6% | 55.9% | -10.5 | 1 845 934 440 | 3.4% | 61.3% | -9.1 | 9.8% |
| ESPUMISAN BABY | 1 150 630 | -10.3% | 38.2% | -3.6 | 717 704 468 | -3.8% | 51.4% | -5.2 | -1.9% |
| FASTUM | 855 011 | -20.6% | 1.1% | -0.3 | 440 923 580 | -11.0% | 2.5% | -0.6 | 1.9% |
| IODOMARIN | 2 459 499 | 7.9% | 19.9% | 0.2 | 485 977 071 | 13.4% | 9.0% | 0 | 6.9% |
| LIOTON | 1 063 173 | -21.9% | 2.3% | -0.5 | 1 089 097 870 | -2.0% | 4.7% | -0.9 | -6.1% |
| MEZYM | 14 704 550 | -0.7% | 27.2% | -0.6 | 2 250 096 850 | 8.6% | 19.5% | -1.3 | 1.5% |
| MIG 400 | 6 777 858 | -10.0% | 3.4% | -0.5 | 797 470 411 | -6.0% | 2.5% | -0.5 | 3.1% |
| PROSTAMOL | 1 270 573 | -22.2% | 19.4% | -5.7 | 1 782 007 163 | -12.9% | 20.7% | -6.7 | 0.7% |
| RESPERO MYRTOL | 967 524 | 137.3% | 8.9% | 4.9 | 453 191 791 | 135.3% | 8.7% | 4.4 | 5.0% |
| Brand | Volume, packs | Change, % | MS Volume | Change, p.p. | Value, rur | Change, % | MS Value | Change, p.p. | Cat. Volume Change, % |
|---|---|---|---|---|---|---|---|---|---|
| BROMHEXINE B-CH | 12 411 626 | 10.2% | 5.8% | 0.3 | 2 382 768 986 | 27.7% | 5.5% | 0.6 | 3.8% |
| DEXALGIN | 1 930 079 | 9.6% | 0.7% | 0.1 | 794 739 114 | 19.8% | 2.0% | 0.1 | 1.7% |
| ESPUMISAN (ADULTS) | 4 981 705 | -2.0% | 58.0% | -8 | 2 486 110 054 | 9.9% | 63.4% | -6.7 | 11.6% |
| ESPUMISAN BABY | 1 531 636 | -10.8% | 38.6% | -3.1 | 943 058 701 | -3.4% | 52.1% | -3.8 | -3.8% |
| FASTUM | 1 162 438 | -19.3% | 1.2% | -0.3 | 585 852 949 | -10.4% | 2.6% | -0.6 | 1.3% |
| IODOMARIN | 3 346 819 | 25.0% | 20.7% | 2.8 | 649 763 421 | 26.6% | 9.4% | 1.1 | 8.1% |
| LIOTON | 1 394 663 | -18.6% | 2.4% | -0.4 | 1 380 473 357 | 0.1% | 4.9% | -0.7 | -6.0% |
| MEZYM | 20 660 863 | 6.8% | 28.6% | 0.9 | 3 086 347 528 | 14.1% | 20.6% | -0.2 | 3.5% |
| MIG 400 | 9 134 627 | -4.2% | 3.4% | -0.2 | 1 065 787 990 | -0.1% | 2.6% | -0.3 | 1.7% |
| PROSTAMOL | 1 777 865 | -17.0% | 20.3% | -4.4 | 2 435 517 020 | -8.8% | 21.7% | -5.3 | 0.8% |
| RESPERO MYRTOL | 1 306 573 | 127.2% | 8.6% | 4.5 | 605 468 516 | 121.2% | 8.4% | 3.9 | 7.7% |
| Brand | Volume, packs | Change, % | MS Volume | Change, p.p. | Value, rur | Change, % | MS Value | Change, p.p. | Cat. Volume Change, % |
|---|---|---|---|---|---|---|---|---|---|
| BROMHEXINE B-CH | 170 146 | -10.7% | 3.9% | 0.3 | 35 361 434 | -11.1% | 4.0% | 0.2 | -16.5% |
| DEXALGIN | 21 836 | -4.0% | 0.4% | 0.1 | 10 642 519 | -2.8% | 1.4% | 0.2 | -18.5% |
| ESPUMISAN (ADULTS) | 57 131 | -11.5% | 42.9% | -1 | 29 996 333 | -12.3% | 49.0% | -0.3 | -9.5% |
| ESPUMISAN BABY | 24 519 | -10.4% | 33.6% | -1.3 | 16 078 303 | -10.6% | 47.0% | -1.1 | -7.0% |
| FASTUM | 14 858 | -18.5% | 0.8% | -0.1 | 8 416 527 | -16.4% | 2.1% | -0.1 | -10.8% |
| IODOMARIN | 89 074 | -26.8% | 25.2% | -2.8 | 16 395 732 | -26.6% | 11.2% | -3 | -18.6% |
| LIOTON | 16 053 | -14.6% | 1.7% | -0.1 | 17 323 613 | -15.7% | 3.7% | 0 | -10.5% |
| MEZYM | 217 591 | -12.0% | 18.9% | 0.4 | 34 072 187 | -9.4% | 13.9% | 0.8 | -13.7% |
| MIG 400 | 140 488 | -18.5% | 2.8% | 0 | 16 923 139 | -18.2% | 2.2% | 0 | -18.5% |
| PROSTAMOL | 28 814 | 11.1% | 17.7% | 3 | 39 937 140 | 10.2% | 18.7% | 3 | -8.0% |
| RESPERO MYRTOL | 28 451 | -0.2% | 9.3% | 1.7 | 13 954 205 | 1.7% | 9.7% | 1.7 | -18.3% |
| Brand | Volume, packs | Change, % | MS Volume | Change, p.p. | Value, rur | Change, % | MS Value | Change, p.p. | Cat. Volume Change, % |
|---|---|---|---|---|---|---|---|---|---|
| BROMHEXINE B-CH | 747 528 | 79.1% | 3.7% | 0 | 153 590 034 | 85.1% | 3.8% | 0.1 | 81.0% |
| DEXALGIN | 90 811 | 16.9% | 0.4% | 0 | 43 312 453 | 19.6% | 1.1% | 0 | 21.7% |
| ESPUMISAN (ADULTS) | 281 557 | 10.8% | 46.3% | -0.4 | 148 737 462 | 10.9% | 52.0% | -0.6 | 11.7% |
| ESPUMISAN BABY | 112 687 | 10.3% | 34.9% | -0.1 | 73 791 527 | 12.4% | 48.2% | 0.5 | 10.7% |
| FASTUM | 77 456 | 19.6% | 0.9% | 0 | 42 173 280 | 18.5% | 2.2% | 0.1 | 15.2% |
| IODOMARIN | 335 689 | 32.6% | 24.3% | 2.3 | 62 171 772 | 28.4% | 10.7% | 1 | 20.3% |
| LIOTON | 83 625 | -9.1% | 1.8% | -0.2 | 90 280 193 | -8.4% | 3.9% | -0.4 | 1.3% |
| MEZYM | 1 012 478 | 8.5% | 18.9% | -0.8 | 154 387 022 | 9.1% | 13.4% | -0.5 | 13.2% |
| MIG 400 | 705 306 | 16.2% | 2.8% | -0.1 | 83 916 288 | 16.1% | 2.2% | 0 | 21.7% |
| PROSTAMOL | 107 142 | 27.2% | 15.1% | 0 | 149 162 441 | 25.9% | 16.1% | 0.2 | 27.1% |
| RESPERO MYRTOL | 111 511 | 68.8% | 7.7% | -1.4 | 53 402 083 | 71.8% | 8.0% | -1.2 | 99.0% |
ОБОЗНАЧЕНИЯ
WoW - Week Over Week - показатели для сравнения результатов текущей и предыдущей недели
MoM - Month Over Month - показатели для сравнения результатов последнего полного месяца и предыдущего полного месяца
YTD - Year to Date - показатели для сравнения результатов за период времени, начинающийся с первого дня текущего календарного года до текущей даты с результатами за сопоставимый период прошлого года
MAT - Moving Annual Total - показатели для сравнения результатов за период 12 месяцев, с датой окончания на последней доступной неделе, с результатами за сопоставимый период прошлого года
MS - Market Share - Доля рынка = (Продажи бренда / Продажи категории)*100%
Change, % = (Продажи бренда за последний период / Продажи бренда за предыдущий период - 1)*100%
Change, p.p. = Доля бренда на рынке за последний период - Доля бренда на рынке за предыдущий период (выражается в процентных пунктах)
Cat. Volume Change, % = (Продажи категории в упаковках за последний период / Продажи категории в упаковках за предыдущий период - 1)*100%
Каждая категория собрана специально для каждого бренда и включает в себя бренд и его конкурентов
Список конкурентов можно найти в разделе "MS of competitors" в блоке каждого бренда
ABBREVIATIONS
WoW - Week Over Week - indicators for comparing the results of the current and previous week
MoM - Month Over Month - indicators for comparing the results of the* last full month* and previous full month
YTD - Year to Date - indicators for comparing the results of the period of time beginning the first day of the current calendar year up to the current date with the results of the comparable period last year
MAT - Moving Annual Total - indicators for comparing the results of the period, being 12 month period ending on the last week with the results of the comparable period last year
MS - Market Share - (Brand Sales / Category Sales)*100%
Change, % = (Brand Sales of the last period / Brand Sales of the previous period - 1)*100%
Change, p.p. = Brand Market Share of the last period - Brand Market Share of the previous period (expressed in percentage points)
Cat. Volume Change, % = (Category Sales in packs of the last period / Category Sales in packs of the previous period - 1)*100%
Each category is created specifically for each brand and includes the brand and its competitors
The list of competitors can be found in the subsection "MS of competitors" in sections for each brand
## [1] "BROMHEXINE B-CH"## [1] "BROMHEXINE B-CH COATED TABLETS 8 MG #25"## [1] "BROMHEXINE B-CH SOL ORAL 4 MG/5 ML 60 ML #1"## [1] "ESPUMISAN (ADULTS)"## [1] "ESPUMISAN (ADULTS) CAPS 40 MG #25"## [1] "ESPUMISAN (ADULTS) CAPS 40 MG #50"## [1] "ESPUMISAN (ADULTS) EXTRA GRAN 125 MG #14"## [1] "ESPUMISAN (ADULTS) L EMULS ORAL 40 MG 30 ML #1"## [1] "ESPUMISAN BABY"## [1] "ESPUMISAN BABY ORAL DROPS 100 MG/ML 30 ML #1"## [1] "ESPUMISAN BABY ORAL DROPS 100 MG/ML 50 ML #1"## [1] "FASTUM"## [1] "FASTUM GEL FOR EXT USE 2,5% 100 G #1"## [1] "FASTUM GEL FOR EXT USE 2,5% 30 G #1"## [1] "FASTUM GEL FOR EXT USE 2,5% 50 G #1"## [1] "LIOTON"## [1] "LIOTON 1000 GEL FOR EXT USE 1000 IU/G 100 G #1"## [1] "LIOTON 1000 GEL FOR EXT USE 1000 IU/G 30 G #1"## [1] "LIOTON 1000 GEL FOR EXT USE 1000 IU/G 50 G #1"## [1] "MEZYM"## [1] "MEZYM 20000 INTESTINAL-SOLUBLE COATED TABLETS #20"## [1] "MEZYM FORTE COATED TABLETS #20"## [1] "MEZYM FORTE COATED TABLETS #80"## [1] "MEZYM NEO 10000 CAPS ENTEROSOLUB 10000 IU #20"## [1] "MEZYM NEO 10000 CAPS ENTEROSOLUB 10000 IU #50"## [1] "MEZYM NEO 25000 CAPS ENTEROSOLUB 25000 IU #20"## [1] "MEZYM NEO 25000 CAPS ENTEROSOLUB 25000 IU #50"## [1] "MEZYM PRO INTESTINAL-SOLUBLE COATED TABLETS #20"## [1] "DEXALGIN"## [1] "DEXALGIN 25 COATED TABLETS 25 MG #10"## [1] "MIG 400"## [1] "MIG 400 COATED TABLETS 400 MG #10"## [1] "MIG 400 COATED TABLETS 400 MG #20"## [1] "PROSTAMOL"## [1] "PROSTAMOL UNO CAPS 320 MG #30"## [1] "PROSTAMOL UNO CAPS 320 MG #60"## [1] "PROSTAMOL UNO CAPS 320 MG #90"## [1] "IODOMARIN"## [1] "IODOMARIN 100 TABS 100 MCG #100"## [1] "IODOMARIN 200 TABS 200 MCG #100"## [1] "IODOMARIN 200 TABS 200 MCG #50"## [1] "IODOMARIN FOR THE FUTURE MOTHER TABLETS 140 MG #30"## [1] "RESPERO MYRTOL"## [1] "RESPERO MYRTOL CAPS ENTEROSOLUB 120 MG #20"## [1] "RESPERO MYRTOL FORTE CAPS ENTEROSOLUB 300 MG #20"[RUS] ОБОЗНАЧЕНИЯ
WoW - Week Over Week - показатели для сравнения результатов текущей и предыдущей недели
MoM - Month Over Month - показатели для сравнения результатов последнего полного месяца и предыдущего полного месяца
YTD - Year to Date - показатели для сравнения результатов за период времени, начинающийся с первого дня текущего календарного года до текущей даты с результатами за сопоставимый период прошлого года
MAT - Moving Annual Total - показатели для сравнения результатов за период 12 месяцев, с датой окончания на последней доступной неделе, с результатами за сопоставимый период прошлого года
MS - Market Share - Доля рынка = (Продажи бренда / Продажи категории)*100%
Change, % = (Продажи бренда за последний период / Продажи бренда за предыдущий период - 1)*100%
Change, p.p. = Доля бренда на рынке за последний период - Доля бренда на рынке за предыдущий период (выражается в процентных пунктах)
Cat. Volume Change, % = (Продажи категории в упаковках за последний период / Продажи категории в упаковках за предыдущий период - 1)*100%
Каждая категория собрана специально для каждого бренда и включает в себя бренд и его конкурентов
Список конкурентов можно найти в разделе "MS of competitors" в блоке каждого бренда
[ENG] ABBREVIATIONS
WoW - Week Over Week - indicators for comparing the results of the current and previous week
MoM - Month Over Month - indicators for comparing the results of the last full month and previous full month
YTD - Year to Date - indicators for comparing the results of the period of time beginning the first day of the current calendar year up to the current date with the results of the comparable period last year
MAT - Moving Annual Total - indicators for comparing the results of the period, being 12 month period ending on the last week with the results of the comparable period last year
MS - Market Share - (Brand Sales / Category Sales)*100%
Change, % = (Brand Sales of the last period / Brand Sales of the previous period - 1)*100%
Change, p.p. = Brand Market Share of the last period - Brand Market Share of the previous period (expressed in percentage points)
Cat. Volume Change, % = (Category Sales in packs of the last period / Category Sales in packs of the previous period - 1)*100%
Each category is created specifically for each brand and includes the brand and its competitors
The list of competitors can be found in the subsection "MS of competitors" in sections for each brand
DATA SOURCES:
DSM: Sales
Palomars: TRPs
MI: Fact Digital Costs
MI Estimated Costs: TV costs